Latest Contracts And Customers News

Paladin Energy kept its FY2027 production and cost targets unchanged despite a softer first quarter at Langer Heinrich, where planned maintenance and lower recovery reduced output. Higher realised uranium prices and progress at the Patterson Lake South project provided the more constructive elements of the update.

Nuix has returned to statutory profit and generated substantially more cash in FY26, while its Nuix Neo platform became the main engine of growth. The annual report also flags a planned $5 million restructuring, an undisclosed insurance provision and unresolved litigation risks.

Norwood Systems delivered higher revenue, record customer receipts and a sharp reduction in operating cash outflow in FY2026. But the ASX-listed AI voice company remains loss-making, cash-light and subject to a material going-concern uncertainty.

Radiopharm Theranostics reported a A$56.3 million comprehensive loss for fiscal 2026, with operating cash outflows rising to A$52.8 million and cash falling to A$4.1 million. The company says further funding is required, while auditors flag a material uncertainty over its ability to continue as a going concern.

Vection Technologies delivered its first positive full-year operating cash flow and a sharp rise in adjusted EBITDA in FY26. Yet the audited report warns that continued operations depend on stronger sales, margin gains, cost reductions and potential access to further capital.

Identitii’s BNDRY platform gained customers and recurring revenue in FY26, but the company ended the year with just $107,483 in cash, negative net assets and a material uncertainty over its ability to continue as a going concern. A subsequent convertible note facility provides a committed $5 million, while access to a further $15 million remains conditional.

AnteoTech reduced its FY2026 loss and strengthened its balance sheet, but auditors warned that a material uncertainty remains over the company’s ability to continue as a going concern. Commercial revenue fell sharply as battery and diagnostics opportunities remained largely in evaluation or negotiation.

Ramsay Health Care delivered stronger FY26 earnings, a higher fully franked dividend and improved Funding Group leverage as it prepares to separate Ramsay Santé. The proposed demerger remains conditional, but the company has set a clear timetable for the next phase of its portfolio reshaping.

Metcash delivered $558 million of operating cash flow and 2.8% ex-tobacco sales growth in the first 18 weeks of FY27, but warned that cost inflation, adverse sales mix and tobacco changes will weigh on first-half earnings. The group also expects to spend a further $18 million to $20 million on its Horizon technology program.

KTEK Aerosystems has secured a US$172,500 turnkey contract to design, tool and manufacture two composite prototypes for Israel-based Vestal Technology. The work adds a new customer, but any production beyond the prototypes remains uncertain.

Orcoda Limited reported a 26% reduction in net loss and a 23% rise in Annual Recurring Revenue, boosted by a new $8 million per annum multi-year contract with Wagner Corporation, setting the stage for SaaS expansion in FY27.

WiseTech Global posted a record $1.4 billion in revenue for FY26, driven by the e2open acquisition and AI-led efficiencies, while underlying net profit rose 29%. The company outlines a confident FY27 growth outlook amid ongoing integration and innovation.